RELAPSING FORMS OF MULTIPLE SCLEROSIS
Clinical trials for RELAPSING FORMS OF MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING FORMS OF MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for RELAPSING FORMS OF MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MS drug combo shows promise in early trial
Disease control CompletedThis study tested an experimental drug called BIIB091, alone or combined with an approved MS drug (diroximel fumarate), in 127 people with relapsing multiple sclerosis. The goal was to check safety and see if it reduces brain inflammation on MRI scans. Participants took pills twi…
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Phase: PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Spanish study checks Real-World use of MS drug ofatumumab
Disease control CompletedThis completed study in Spain looked at 310 people with relapsing multiple sclerosis who were taking ofatumumab (Kesimpta®). Researchers wanted to see how well the drug reduced relapses and how safe it was in everyday medical practice. The study collected information from medical…
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New MS drug shows promise for asian patients in safety trial
Disease control CompletedThis phase 3 study tested the safety and tolerability of diroximel fumarate (Vumerity) in 136 East Asian adults with relapsing forms of multiple sclerosis. Participants took the drug for up to 48 weeks, and researchers monitored side effects, lab results, and drug levels in the b…
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC